Haodong Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Haodong Li has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Chwee Teck Lim
Department of Biomedical Engineering, National University of Singapore
2 shared publications - Shaofei Shen
Shanxi Key Lab for Modernization of TCVM, College of Life Science, Shanxi Agricultural University, Taiyuan 030000, Shanxi, P. R. China
2 shared publications - Xiaoyan Liu
Institute for Health Innovation and Technology, National University of Singapore
2 shared publications - Jie Bai
Department of Big Data and Intelligent Engineering, Shanxi Institute of Technology, Yangquan 045000, Shanxi, P. R. China
1 shared publication - Junwei Li
School of Mechanical and Aerospace Engineering, Nanyang Technological University, 50 Nanyang Avenue, Singapore 639798, Singapore
1 shared publication Linwei Li
College of Information Science and Engineering, Shanxi Agricultural University, Taiyuan 030000, Shanxi, P. R. China
1 shared publication
Latest Publications
- Open Access
- 4 August 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (32)
High-throughput deformability-based microfluidic sorting reveals metastatic cancer subpopulations
The deformability of cancer cells is a critical indicator of their malignancy, as this mechanical property of cancer cells can reflect various biostructural and biochemical changes such as the cytoskeletons and protein expressions. However, selectively isolating and analyzing cell subpopulations with differing deformability and their associated biological properties remains challenging, especially at high throughput. Here, we introduce a microstructure-assisted spiral microfluidic platform that sorts cancer cells based on their deformability at ultrahigh throughput (>2,000,000 cells min −1 ) and couples the workflow to real-time, image-based phenotyping of cell parameters. We profile the sorted fractions and investigate a tripartite correlation between the deformability of cancer cells, the expression of proteins in different subpopulations, and the metastatic ability of cancer cells. This tripartite correlation has been confirmed in human breast cancer cell lines with metastatic potential (including MDA-MB-231 cells and BT-549 cells), where these cells are classified into subpopulations based on their deformability. The more deformable subpopulation exhibits increased invasiveness and distinct cytoskeletal remodeling and epithelial-to-mesenchymal transition (EMT)-associated protein signatures. Leveraging these deformability differences, our label-free platform enables high-throughput enrichment of aggressive cancer subpopulations and provides a scalable front end for liquid biopsy workflows. More broadly, deformability-based sorting may support improved analysis of rare metastasis-prone cells and accelerate high-throughput screening for mechano-targeted therapeutic strategies, offering a practical route to integrate cell deformability into precision oncology and therapy.
- 4 August 2026
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (32)
Open AccessHigh-throughput deformability-based microfluidic sorting reveals metastatic cancer subpopulations
The deformability of cancer cells is a critical indicator of their malignancy, as this mechanical property of cancer cells can reflect various biostructural and biochemical changes such as the cytoskeletons and protein expressions. However, selectively isolating and analyzing cell subpopulations with differing deformability and their associated biological properties remains challenging, especially at high throughput. Here, we introduce a microstructure-assisted spiral microfluidic platform that sorts cancer cells based on their deformability at ultrahigh throughput (>2,000,000 cells min −1 ) and couples the workflow to real-time, image-based phenotyping of cell parameters. We profile the sorted fractions and investigate a tripartite correlation between the deformability of cancer cells, the expression of proteins in different subpopulations, and the metastatic ability of cancer cells. This tripartite correlation has been confirmed in human breast cancer cell lines with metastatic potential (including MDA-MB-231 cells and BT-549 cells), where these cells are classified into subpopulations based on their deformability. The more deformable subpopulation exhibits increased invasiveness and distinct cytoskeletal remodeling and epithelial-to-mesenchymal transition (EMT)-associated protein signatures. Leveraging these deformability differences, our label-free platform enables high-throughput enrichment of aggressive cancer subpopulations and provides a scalable front end for liquid biopsy workflows. More broadly, deformability-based sorting may support improved analysis of rare metastasis-prone cells and accelerate high-throughput screening for mechano-targeted therapeutic strategies, offering a practical route to integrate cell deformability into precision oncology and therapy.
- Open Access
- 19 December 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (51) , eaea6007
Advances in machine learning–enhanced microfluidic cell sorting
Cell sorting, essential for diagnostics and early intervention, has evolved from conventional methods to sophisticated microfluidic approaches. These miniaturized systems leverage precise hydrodynamic control, facilitating major advances in tumor cell isolation, single-cell analysis, and biomarker detection. However, the vast imaging data generated by these microfluidic techniques necessitate advanced computational methods. Machine learning, particularly computer vision and deep learning, now offers transformative capabilities for automated feature extraction, pattern recognition, and real-time classification, enhancing sorting accuracy, accelerating diagnostics, and informing clinical decisions. This review synthesizes the convergence of microfluidics and machine intelligence, examining their synergistic roles in flow-field optimization, cellular classification, and error correction. While highlighting breakthroughs in diagnostic sensitivity and analytical throughput, we critically address challenges including model generalizability and hardware-software integration. Last, we provide an outlook on multimodal data fusion and the development of on-chip intelligent systems, proposing a roadmap for advancing precision medicine through embedded, adaptive biosensing platforms.
- 19 December 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (51) , eaea6007
Open AccessAdvances in machine learning–enhanced microfluidic cell sorting
Cell sorting, essential for diagnostics and early intervention, has evolved from conventional methods to sophisticated microfluidic approaches. These miniaturized systems leverage precise hydrodynamic control, facilitating major advances in tumor cell isolation, single-cell analysis, and biomarker detection. However, the vast imaging data generated by these microfluidic techniques necessitate advanced computational methods. Machine learning, particularly computer vision and deep learning, now offers transformative capabilities for automated feature extraction, pattern recognition, and real-time classification, enhancing sorting accuracy, accelerating diagnostics, and informing clinical decisions. This review synthesizes the convergence of microfluidics and machine intelligence, examining their synergistic roles in flow-field optimization, cellular classification, and error correction. While highlighting breakthroughs in diagnostic sensitivity and analytical throughput, we critically address challenges including model generalizability and hardware-software integration. Last, we provide an outlook on multimodal data fusion and the development of on-chip intelligent systems, proposing a roadmap for advancing precision medicine through embedded, adaptive biosensing platforms.